What’s the use of anti-HIV injections when those who need it most can’t use it?
.png)
In an article for the Mail & Guardian, Yogan Pillay, Francois Venter and Fatima Hassan examine access to the HIV pre-exposure prohpylaxis (PrEP) drug CAB-LA in Sub-Saharan Africa, drawing on results from the Foundation's 2021 Access to Medicine Index.